Home
OrbiMed Capital GP VI, Director: Alpine Immune Sciences ALPN Sell · Filed 23/12/29
Trade details
- Type
- Insider sale
- Amount
- $21,904,912.56
- Shares · price
- 1,195,683 sh · $18.32 a share
- Held after
- 2,270,930 sh
- Trade date
- 23/12/28
- Filed
- 23/12/29
- Days to filing
- 1 days
Sold 34.5% of holdings
- Share of holding sold
- 34.5%
Alpine Immune Sciences trades, last 26 weeks
What else happened in Alpine Immune Sciences around then
Filed or reported within 30 days of the trade day · 23/11/28~24/01/27OrbiMed Capital GP VI's recent trades
- OrbiMed Capital GP VI
BuyPrelude Therapeutics
BuyPrelude Therapeutics
PRLD
$7.5M
1,689,189 sh
$7.5M
Filed 04/23
Traded 04/21
- OrbiMed Capital GP VI
BuyPrelude Therapeutics
BuyPrelude Therapeutics
PRLD
$5M
1,126,126 sh
$5M
Filed 04/23
Traded 04/21
- OrbiMed Capital GP VI
SellAdicet Bio
SellAdicet Bio
ACET
$263.5K
40,416 sh
$263.5K
Filed 04/09
Traded 04/08
- OrbiMed Capital GP VI
SellAdicet Bio
SellAdicet Bio
ACET
$204.6K
32,523 sh
$204.6K
Filed 04/09
Traded 04/08
- OrbiMed Capital GP VI
SellAdicet Bio
SellAdicet Bio
ACET
$191.5K
29,319 sh
$191.5K
Filed 04/09
Traded 04/07
